Abstract
AbstractPurposeWe examined the association between sociodemographic, personal, and disease-related determinants and referral to a new model of health care that uses patient-reported outcomes (PRO) measures for remote outpatient follow-up (PRO-based follow-up).MethodsWe conducted a prospective cohort study among outpatients with epilepsy at the Department of Neurology at Aarhus University Hospital, Denmark. Included were all persons aged ≥ 15 years visiting the department for the first time during the period from May 2016 to May 2018. Patients received a questionnaire containing questions about health literacy, self-efficacy, patient activation, well-being, and general health. We also collected data regarding sociodemographic status, labour market affiliation, and co-morbidity from nationwide registers. Associations were analysed as time-to-event using the pseudo-value approach. Missing data were handled using multiple imputations.ResultsA total of 802 eligible patients were included in the register-based analyses and 411 patients (51%) responded to the questionnaire. The results based on data from registers indicated that patients were less likely to be referred to PRO-based follow-up if they lived alone, had low education or household income, received temporary or permanent social benefits, or if they had a psychiatric diagnosis. The results based on data from the questionnaire indicated that patients were less likely to be referred to PRO-based follow-up if they reported low levels of health literacy, self-efficacy, patient activation, well-being, or general health.ConclusionBoth self-reported and register-based analyses indicated that socioeconomically advantaged patients were referred more often to PRO-based follow-up than socioeconomically disadvantaged patients.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference52 articles.
1. Hvidberg, M. F., Johnsen, S. P., Davidsen, M., & Ehlers, L. (2019). A nationwide study of prevalence rates and characteristics of 199 chronic conditions in Denmark. PharmacoEconomics-open.
2. US Department of Health and Human Services Food and Drug Administration. (2009). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Retrieved February 20 2019 from www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.
3. Calvert, M., Kyte, D., Price, G., Valderas, J. M., & Hjollund, N. H. (2019). Maximising the impact of patient reported outcome assessment for patients and society. BMJ (Clinical Research ed.),364, k5267.
4. Greenhalgh, J. (2009). The applications of PROs in clinical practice: what are they, do they work, and why? Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,18(1), 115–123.
5. Schougaard, L. M., Larsen, L. P., Jessen, A., Sidenius, P., Dorflinger, L., de Thurah, A., et al. (2016). AmbuFlex: tele-patient-reported outcomes (telePRO) as the basis for follow-up in chronic and malignant diseases. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation,25(3), 525–534.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献